Cargando…

Survival Time to COVID-19 Severity and Its Predictors in South Gondar Zone, North-West Ethiopia: A Prospective Cohort Study

BACKGROUND: Coronavirus disease is still a global public health emergency. Due to an inadequate healthcare system in low-income nations like Ethiopia, the pandemic has had a devastating impact. Despite this, information on the severity of COVID-19 and related difficulties in Ethiopia is sparse. Ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Yemata, Getaneh Atikilt, Tesfaw, Aragaw, Mihret, Gashaw, Tiruneh, Mulu, Walle, Zebader, Molla, Eshetie, Sisay, Ermias, Admassu, Fitalew Tadele, Habtie, Eyaya, Desalagn, Tsion, Shimels, Habtamu, Teshome, Fentaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139343/
https://www.ncbi.nlm.nih.gov/pubmed/35634568
http://dx.doi.org/10.2147/JMDH.S361061
_version_ 1784714837385805824
author Yemata, Getaneh Atikilt
Tesfaw, Aragaw
Mihret, Gashaw
Tiruneh, Mulu
Walle, Zebader
Molla, Eshetie
Sisay, Ermias
Admassu, Fitalew Tadele
Habtie, Eyaya
Desalagn, Tsion
Shimels, Habtamu
Teshome, Fentaw
author_facet Yemata, Getaneh Atikilt
Tesfaw, Aragaw
Mihret, Gashaw
Tiruneh, Mulu
Walle, Zebader
Molla, Eshetie
Sisay, Ermias
Admassu, Fitalew Tadele
Habtie, Eyaya
Desalagn, Tsion
Shimels, Habtamu
Teshome, Fentaw
author_sort Yemata, Getaneh Atikilt
collection PubMed
description BACKGROUND: Coronavirus disease is still a global public health emergency. Due to an inadequate healthcare system in low-income nations like Ethiopia, the pandemic has had a devastating impact. Despite this, information on the severity of COVID-19 and related difficulties in Ethiopia is sparse. Therefore, we aimed to determine the survival time to severity and predictors of COVID-19 in Northwest Ethiopia. METHODS: A prospective follow-up study was conducted among 202 adult COVID-19 patients in the South Gondar zone treatment centers. Data were entered using EpiData version 3.1 and then exported to Stata 16 for analysis. Kaplan–Meier was used to estimate mean survival time, and Log rank tests were used to compare survival time between explanatory variable groups. A cox-proportional hazards regression model with a 95% confidence interval and a p-value of 0.05 was used to identify covariates associated with the outcome variable. RESULTS: The patients’ average age was 41.2 years. With an IQR of 4–7 days, the median time to COVID-19 severity was 5 days. The overall COVID-19 severity rate was 6.35 (95% CI: 5.17–7.86) per 100 person-days observed. Senior adult age group (51–59 years) (AHR = 3.59, 95% CI: 1.05, 12.23), elderly age group (≥60 years) (AHR = 2.11, 95% CI: 1.09, 12.67), comorbidity (AHR = 3.26, 95% CI: 1.48, 7.18), high blood pressure at admission (AHR = 4.36, 95% CI: 1.99, 9.54), and high temperature at admission (AHR = 5.60, 95% CI: 2.55, 12.46) were significantly associated with COVID-19 severity time. CONCLUSION AND RECOMMENDATION: Patients with COVID-19 had a short median severity time, and factors like older age, comorbidity, high temperature, and high blood pressure were all independent predictors of severity time. Patients with high body temperature, blood pressure, comorbidity, and advanced age should be the focus of interventions to reduce progression time and improve clinical outcomes.
format Online
Article
Text
id pubmed-9139343
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-91393432022-05-28 Survival Time to COVID-19 Severity and Its Predictors in South Gondar Zone, North-West Ethiopia: A Prospective Cohort Study Yemata, Getaneh Atikilt Tesfaw, Aragaw Mihret, Gashaw Tiruneh, Mulu Walle, Zebader Molla, Eshetie Sisay, Ermias Admassu, Fitalew Tadele Habtie, Eyaya Desalagn, Tsion Shimels, Habtamu Teshome, Fentaw J Multidiscip Healthc Original Research BACKGROUND: Coronavirus disease is still a global public health emergency. Due to an inadequate healthcare system in low-income nations like Ethiopia, the pandemic has had a devastating impact. Despite this, information on the severity of COVID-19 and related difficulties in Ethiopia is sparse. Therefore, we aimed to determine the survival time to severity and predictors of COVID-19 in Northwest Ethiopia. METHODS: A prospective follow-up study was conducted among 202 adult COVID-19 patients in the South Gondar zone treatment centers. Data were entered using EpiData version 3.1 and then exported to Stata 16 for analysis. Kaplan–Meier was used to estimate mean survival time, and Log rank tests were used to compare survival time between explanatory variable groups. A cox-proportional hazards regression model with a 95% confidence interval and a p-value of 0.05 was used to identify covariates associated with the outcome variable. RESULTS: The patients’ average age was 41.2 years. With an IQR of 4–7 days, the median time to COVID-19 severity was 5 days. The overall COVID-19 severity rate was 6.35 (95% CI: 5.17–7.86) per 100 person-days observed. Senior adult age group (51–59 years) (AHR = 3.59, 95% CI: 1.05, 12.23), elderly age group (≥60 years) (AHR = 2.11, 95% CI: 1.09, 12.67), comorbidity (AHR = 3.26, 95% CI: 1.48, 7.18), high blood pressure at admission (AHR = 4.36, 95% CI: 1.99, 9.54), and high temperature at admission (AHR = 5.60, 95% CI: 2.55, 12.46) were significantly associated with COVID-19 severity time. CONCLUSION AND RECOMMENDATION: Patients with COVID-19 had a short median severity time, and factors like older age, comorbidity, high temperature, and high blood pressure were all independent predictors of severity time. Patients with high body temperature, blood pressure, comorbidity, and advanced age should be the focus of interventions to reduce progression time and improve clinical outcomes. Dove 2022-05-23 /pmc/articles/PMC9139343/ /pubmed/35634568 http://dx.doi.org/10.2147/JMDH.S361061 Text en © 2022 Yemata et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Yemata, Getaneh Atikilt
Tesfaw, Aragaw
Mihret, Gashaw
Tiruneh, Mulu
Walle, Zebader
Molla, Eshetie
Sisay, Ermias
Admassu, Fitalew Tadele
Habtie, Eyaya
Desalagn, Tsion
Shimels, Habtamu
Teshome, Fentaw
Survival Time to COVID-19 Severity and Its Predictors in South Gondar Zone, North-West Ethiopia: A Prospective Cohort Study
title Survival Time to COVID-19 Severity and Its Predictors in South Gondar Zone, North-West Ethiopia: A Prospective Cohort Study
title_full Survival Time to COVID-19 Severity and Its Predictors in South Gondar Zone, North-West Ethiopia: A Prospective Cohort Study
title_fullStr Survival Time to COVID-19 Severity and Its Predictors in South Gondar Zone, North-West Ethiopia: A Prospective Cohort Study
title_full_unstemmed Survival Time to COVID-19 Severity and Its Predictors in South Gondar Zone, North-West Ethiopia: A Prospective Cohort Study
title_short Survival Time to COVID-19 Severity and Its Predictors in South Gondar Zone, North-West Ethiopia: A Prospective Cohort Study
title_sort survival time to covid-19 severity and its predictors in south gondar zone, north-west ethiopia: a prospective cohort study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139343/
https://www.ncbi.nlm.nih.gov/pubmed/35634568
http://dx.doi.org/10.2147/JMDH.S361061
work_keys_str_mv AT yematagetanehatikilt survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy
AT tesfawaragaw survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy
AT mihretgashaw survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy
AT tirunehmulu survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy
AT wallezebader survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy
AT mollaeshetie survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy
AT sisayermias survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy
AT admassufitalewtadele survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy
AT habtieeyaya survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy
AT desalagntsion survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy
AT shimelshabtamu survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy
AT teshomefentaw survivaltimetocovid19severityanditspredictorsinsouthgondarzonenorthwestethiopiaaprospectivecohortstudy